Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Consensus Pharmaceuticals Inc.

Latest From Consensus Pharmaceuticals Inc.

NICE Should Ape Swiss HTA, Says Roche CEO

The chief executive of the world's biggest maker of cancer drugs believes the drug approval process used by the UK's National Institute of Health and Care Excellence's needs revamping and that the country should look to Switzerland for a model to emulate.

Cancer Switzerland

Faron Pharmaceuticals floats as lead product enters Phase III

Turku, Finland-based Faron Pharmaceuticals has floated on the London Stock Exchange's Alternative Investment Market (AIM), raising £10m to fund a Phase III trial for its lead product, orphan drug Traumakine.

Gastrointestinal Cardiovascular

Brandicourt's 'Big Reveal' Falls Flat For Sanofi

Seven months into the job and the shine is wearing off Sanofi's new CEO Olivier Brandicourt. His first 'Meet the Management' investor day on Nov. 6 left analysts underwhelmed and shares slipping.

Metabolic Disorders Orthopedics

PRAC relief for HPV vaccines

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has found no evidence to support a causal link between the marketed HPV vaccines and two rare conditions after a review of the latest scientific knowledge.

Cardiovascular Neurology
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics